| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1517/14622416.3.2.219 |
| P698 | PubMed publication ID | 11972443 |
| P2093 | author name string | Andrew P Smith | |
| Nancy M Lee | |||
| P2860 | cites work | Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction | Q24320057 |
| G-protein-coupled receptor heterodimerization modulates receptor function | Q24603239 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus | Q28771769 | ||
| Threonine 180 is required for G-protein-coupled receptor kinase 3- and beta-arrestin 2-mediated desensitization of the mu-opioid receptor in Xenopus oocytes | Q31520490 | ||
| A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling | Q31532158 | ||
| The genetic mediation of individual differences in sensitivity to pain and its inhibition | Q33679576 | ||
| The mu opiate receptor as a candidate gene for pain: polymorphisms, variations in expression, nociception, and opiate responses | Q33679584 | ||
| Studies on mu and delta opioid receptor selectivity utilizing chimeric and site-mutagenized receptors | Q33679621 | ||
| Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoter | Q34401595 | ||
| Genomic structure analysis of promoter sequence of a mouse mu opioid receptor gene | Q35762035 | ||
| Identification of a neurorestrictive suppressor element (NRSE) in the human mu-opioid receptor gene | Q38298930 | ||
| Phosphorylation of Ser363, Thr370, and Ser375 residues within the carboxyl tail differentially regulates mu-opioid receptor internalization. | Q40817051 | ||
| Localization of promoter elements in the human mu-opioid receptor gene and regulation by DNA methylation | Q40946137 | ||
| A conserved arginine in the distal third intracellular loop of the mu-opioid receptor is required for G protein activation | Q40970998 | ||
| Identification of serine 356 and serine 363 as the amino acids involved in etorphine-induced down-regulation of the mu-opioid receptor. | Q40988621 | ||
| Dual promoters of mouse mu-opioid receptor gene | Q41109711 | ||
| Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene | Q41157124 | ||
| Modulation of mu-mediated antinociception by delta agonists in the mouse: selective potentiation of morphine and normorphine by [D-Pen2,D-Pen5]enkephalin | Q41271778 | ||
| Pharmacology and regulation of the neuronal dopamine transporter | Q41460319 | ||
| Genetic sensitivity to hot-plate nociception in DBA/2J and C57BL/6J inbred mouse strains: possible sex-specific mediation by delta2-opioid receptors | Q42438400 | ||
| Single nucleotide polymorphisms in the human mu opioid receptor gene alter basal G protein coupling and calmodulin binding | Q42507483 | ||
| Quantitative trait loci influencing morphine antinociception in four mapping populations. | Q43649309 | ||
| Nonreplication of association between mu-opioid-receptor gene (OPRM1) A118G polymorphism and substance dependence | Q43652684 | ||
| Morphine tolerance in mice is independent of polymorphisms in opioid receptor sequences. | Q43654298 | ||
| Transcriptional regulation of the human mu opioid receptor (hMOR) gene: evidence of positive and negative cis-acting elements in the proximal promoter and presence of a distal promoter | Q43708231 | ||
| Morphine tolerance in spinal cord is due to interaction between mu- and delta-receptors | Q43830170 | ||
| Role for the C-terminus in agonist-induced mu opioid receptor phosphorylation and desensitization | Q44331716 | ||
| Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties | Q44331872 | ||
| Identification of the amino acid residues involved in selective agonist binding in the first extracellular loop of the δ‐ and μ‐opioid receptors | Q44333522 | ||
| Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence | Q44333907 | ||
| Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts | Q44335420 | ||
| Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice | Q44342101 | ||
| Association between a delta opioid receptor gene polymorphism and heroin dependence in man. | Q44346554 | ||
| Agonist-induced desensitization of the mu opioid receptor is determined by threonine 394 preceded by acidic amino acids in the COOH-terminal tail | Q44346933 | ||
| Population studies of polymorphisms at loci of neuropsychiatric interest (tryptophan hydroxylase (TPH), dopamine transporter protein (SLC6A3), D3 dopamine receptor (DRD3), apolipoprotein E (APOE), mu opioid receptor (OPRM1), and ciliary neurotrophic | Q44350388 | ||
| Opioid peptide receptor studies, 11: involvement of Tyr148, Trp318 and His319 of the rat mu-opioid receptor in binding of mu-selective ligands | Q44351724 | ||
| Functional role of the spatial proximity of Asp114(2.50) in TMH 2 and Asn332(7.49) in TMH 7 of the mu opioid receptor | Q44351857 | ||
| ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone | Q44352419 | ||
| Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence | Q44352797 | ||
| Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects | Q44352947 | ||
| On the road to understanding addiction | Q47862035 | ||
| The potentiation of spinal analgesia by leucine enkephalin. | Q51877813 | ||
| Genetic and environmental influences on adolescent substance use and abuse. | Q52072100 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | opioid | Q427523 |
| P304 | page(s) | 219-227 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Pharmacogenomics | Q15724625 |
| P1476 | title | Opioid receptor polymorphisms and opioid abuse | |
| P478 | volume | 3 |
Search more.